SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dai-Ichi Karkaria transfers 9.87 lakh shares of Inogent to GVK Biosciences

15 Jul 2014 Evaluate

GVK Biosciences has acquired balance 987,500 equity shares constituting 6.12% of voting powers of Inogent Laboratories from Dai-Ichi Karkaria on July 11, 2014, at a consideration aggregating to Rs 8.97 crore.

GVK Biosciences has acquired the shares pursuant to the call option under the joint venture and shareholders agreement among GVK Biosciences, Dai-Ichi Karkaria and Inogent Laboratories, dated October 14, 2005.

Accordingly, the shareholding of the company in Inogent Laboratories after acquisition by GVK Biosciences will be nil and the agreement shall be treated as concluded.

Dai-Ichi Karkaria Share Price

258.75 -0.40 (-0.15%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3668.45
Tata Chemicals 719.90
SRF 2498.45
Pidilite Inds. 1329.15
Deepak Nitrite 1520.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×